RESÚMENES DICIEMBRE 2005

.

Other Neuropsychiatric Disorders & General Information

(Haga un click en la información del journal para acceder al resúmen)

 

Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial
Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Greenspan A

Int J Geriatr Psychiatry. 2005 Nov 28;20(12):1153-1157

 

Efficacy of milnacipran on poststroke depression on inpatient rehabilitation

YURIKO YAMAKAWA, SHINJI SATOH, SHUNJI SAWA, HITOSHI OHTA, AND TAKASHI ASADA

Psychiatry and Clinical Neurosciences. Volume 59 Issue 6 Page 705  - December 2005

Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications

Philip S. Wang, Sebastian Schneeweiss, Jerry Avorn, Michael A. Fischer, Helen Mogun, Daniel H. Solomon, and M. Alan Brookhart

NEJM. Volume 353:2335-2341; December 1, 2005: Number 22

 

Olanzapine versus propranolol in essential tremor
Yetimalar Y, Irtman G, Kurt T, Basoglu M

Clin Neurol Neurosurg. 2005 Dec;108(1):32-5

 

Sustained-release Bupropion Versus Naltrexone in the Treatment of Pathological Gambling: A Preliminary Blind-rater Study
Dannon PN, Lowengrub K, Musin E, Gonopolski Y, Kotler M

J Clin Psychopharmacol. 2005 Dec;25(6):593-596

 

Insulin resistance in depressive disorders and Alzheimer's disease: Revisiting the missing link hypothesis

Natalie L. Rasgon and Heather A. Kenna

Neurobiology of Aging. Volume 26, Issue 1, Supplement 1, December 2005, Pages 103-107

Fitness, aging and neurocognitive function

Arthur F. Kramer, Stanley J. Colcombe, Edward McAuley, Paige E. Scalf and Kirk I. Erickson

Neurobiology of Aging. Volume 26, Issue 1, Supplement 1, December 2005, Pages 124-127

Risk and protective factors for medically serious suicide attempts: a comparison of hospital-based with population-based samples of young adults

Maria Donald, Jo Dower, Ignacio Correa-Velez, Mark Jones

Australian and New Zealand Journal of Psychiatry. Volume 40 Issue 1 Page 87  - January 2006

Psychiatric comorbidity: concepts, controversies and alternatives

Vladan Starcevic

Australasian Psychiatry. Volume 13 Issue 4 Page 375  - December 2005

 

Low HDL cholesterol is associated with suicide attempt among young healthy women: the Third National Health and Nutrition Examination Survey

Jian Zhang, Robert E. McKeown, James R. Hussey, Shirley J. Thompson, John R. Woods and Barbara E. Ainsworth

Journal of Affective Disorders. Volume 89, Issues 1-3, December 2005, Pages 25-33

 

The effect of pharmacotherapy on personality disorders in panic disorder: A one year naturalistic study

Carlo Marchesi, Alessandro Cantoni, Stefania Fontò, Maria R. Giannelli and Carlo Maggini

Journal of Affective Disorders. Volume 89, Issues 1-3, December 2005, Pages 189-194

 

Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia

J. C. Durán, A. Greenspan, J. I. Diago, R. Gallego and G. Martinez

International Psychogeriatrics (2005), 17: 591-604

 

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics

Sanford Finkel, Chris Kozma, Stacey Long, Andrew Greenspan, Ramy Mahmoud, Onur Baser and Luella Engelhart 

International Psychogeriatrics (2005), 17: 617-629

 

Mortality in individuals who have had psychiatric treatment: Population-based study in Nova Scotia
Kisely S, Smith M, Lawrence D, Maaten S

Br J Psychiatry. 2005 Dec;187:552-558

 

Is grey literature essential for a better control of publication bias in psychiatry? An example from three meta-analyses of schizophrenia

José Luis R. Martin, Víctor Pérez, Montse Sacristán and Enric Álvarez

European Psychiatry. Volume 20, Issue 8, December 2005, Pages 550-553

 

Night Eating Syndrome : Diagnosis, Epidemiology and Management
O'reardon JP, Peshek A, Allison KC

CNS Drugs. 2005;19(12):997-1008

 

Effectiveness of Sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome
Prasanta K Mohapatra, Nilamadhab Kar, Gopal C Kar and Mrutyunjaya Behera
Clinical Practice and Epidemiology in Mental Health 2005, 1:26; 9 December 2005

 

For fibromyalgia, which treatments are the most effective?
Yousefi P, Coffey J

J Fam Pract. 2005 Dec;54(12):1094-5

 

Alzheimer’s disease pathogenesis and therapeutic interventions

M. S. Parihar and Taruna Hemnani

Journal of Clinical Neuroscience. Volume 11, Issue 5, June 2004, Pages 456-467

 

HIV dementia: an evolving disease

Justin C. McArthur

Journal of Neuroimmunology. Volume 157, Issues 1-2, December 2004, Pages 3-10

Looking for pyromania: Characteristics of a consecutive sample of Finnish male criminals with histories of recidivist fire-setting between 1973 and 1993
Nina Lindberg, Matti M Holi, Pekka Tani and Matti Virkkunen
BMC Psychiatry 2005, 5:47; 14 December 2005

 

CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters
Samuelsson M, Jokinen J, Nordström A-L, Nordström P

Acta Psychiatr Scand 2005: 1–4

 

Global prevalence of dementia: a Delphi consensus study

Cleusa P Ferri, ProfMartin Prince, ProfCarol Brayne, ProfHenry Brodaty, ProfLaura Fratiglioni, ProfMary Ganguli, Kathleen Hall, Kazuo Hasegawa, ProfHugh Hendrie, ProfYueqin Huang, ProfAnthony Jorm, Colin Mathers, Paulo R Menezes, Elizabeth Rimmer, Marcia Scazufca and for Alzheimer's Disease International

The Lancet. Volume 366, Issue 9503, 17 December 2005-6 January 2006, Pages 2112-2117

 

Point prevalence of bulimia nervosa in 1982, 1992, and 2002

PAMELA K. KEEL, TODD F. HEATHERTON, DAVID J. DORER, THOMAS E. JOINER and ALYSON K. ZALTA

Psychological Medicine (2006), 36: 119-127

 

Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample

JOSHUA BRESLAU, SERGIO AGUILAR-GAXIOLA, KENNETH S. KENDLER, MAXWELL SU, DAVID WILLIAMS and RONALD C. KESSLER

Psychological Medicine (2006), 36: 57-68

 

Drugs, Memory, and Metamemory: A Dose-Effect Study With Lorazepam and Scopolamine

Miriam Z. Mintzer and Roland R. Griffiths

Experimental and Clinical Psychopharmacology. Volume 13, Issue 4, November 2005, Pages 336-347

 

 

Distributed neural actions of anti-parkinsonian therapies as revealed by PET

I. K. Goerendt, A. D. Lawrence, M. A. Mehta, J. S. Stern, P. Odin and D. J. Brooks

Journal of Neural Transmission 2006; Volume 113, Number 1: 75 - 86

 

Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode

Luis Pintor, Eva Baillès, Francesc Valldeoriola, Eduard Tolosa, María J. Martí and Joan de Pablo

General Hospital Psychiatry. Volume 28, Issue 1, January-February 2006, Pages 59-64

 

Plasma serotonin levels and suicidal behavior in adolescents

Samuel Tyano, Gil Zalsman, Hadas Ofek, Ilanan Blum, Alan Apter, Luisa Wolovik, Leo Sher, Eliane Sommerfeld, Daniella Harell and Abraham Weizman

European Neuropsychopharmacology. Volume 16, Issue 1, January 2006, Pages 49-57

 

.

Regresar a RESÚMENES DICIEMBRE 2005